A randomized, double-blind crossover study to investigate the potential glucose-lowering interaction between ethanol and GK Activator (2) [RO 4389620] in patients with type 2 diabetes

Trial Profile

A randomized, double-blind crossover study to investigate the potential glucose-lowering interaction between ethanol and GK Activator (2) [RO 4389620] in patients with type 2 diabetes

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Feb 2010

At a glance

  • Drugs Piragliatin (Primary) ; Alcohol
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacokinetics
  • Sponsors Roche
  • Most Recent Events

    • 08 Jan 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top